GRI Bio, Inc. GRI Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001824293-25-000073
cik 1824293
name GRI BIO, INC.
sic 2834
countryba US
stprba CA
cityba LA JOLLA
zipba 92037
bas1 2223 AVENIDA DE LA PLAYA
bas2 SUITE 208
baph (619) 400-1171
countryma US
stprma CA
cityma LA JOLLA
zipma 92037
mas1 2223 AVENIDA DE LA PLAYA
mas2 SUITE 208
countryinc US
stprinc DE
ein 824369909
former GRI BIO, INC.
changed 20230424
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250515
accepted 2025-05-15 08:39:00.0
prevrpt 0
detail 1
instance ck0001824293-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001824293-25-000073 20250331 Accounts Payable Current 1361000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 220000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 220000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -1747000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Common Stock Shares Issued 525358.0000 shares 0 us-gaap/2024
0001824293-25-000073 20250331 Increase Decrease In Accrued Liabilities 562000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Liabilities And Stockholders Equity 5739000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Net Income Loss -1887000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001824293-25-000073 20240331 Operating Expenses 1895000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Operating Income Loss -1895000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Operating Lease Liability Noncurrent 71000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Prepaid Expense And Other Assets Current 587000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Proceeds From Issuance Of Common Stock 3605000.0000 USD 0 us-gaap/2024 Subsidiary Sale Of Stock= At The Market Offering;
0001824293-25-000073 20250331 Weighted Average Number Of Shares Outstanding Basic 525447.0000 shares 1 us-gaap/2024
0001824293-25-000073 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 37000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20241231 Cash And Cash Equivalents At Carrying Value 5028000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 5028000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Change In Fair Value Of Warrant Liability 2000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001824293-25-000073 20240331 Depreciation 1000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Depreciation 1000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Earnings Per Share Diluted -5.8000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Increase Decrease In Accounts Payable 331000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Increase Decrease In Operating Lease Liability -14000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Liabilities 1707000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Liabilities 2837000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Liabilities Current 1636000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Net Income Loss -1887000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Net Income Loss -3046000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001824293-25-000073 20250331 Operating Income Loss -3051000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Operating Lease Liability Current 48000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Proceeds From Issuance Of Common Stock 0.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= Through Financing;
0001824293-25-000073 20250331 Property Plant And Equipment Net 3000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Stockholders Equity 2798000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Stockholders Equity -33420000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001824293-25-000073 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20240331 Stock Issued During Period Shares Warrant Exercise 10047.0000 shares 1 0001824293-25-000073 Equity Components= Common Stock;
0001824293-25-000073 20240331 Stock Issued During Period Value New Issues 4389000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Stock Issued During Period Value New Issues 4389000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20241231 Assets 5739000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Accounts Payable Current 897000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 4091000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3281000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Common Stock Shares Issued 525485.0000 shares 0 us-gaap/2024
0001824293-25-000073 20240331 Earnings Per Share Basic -101.0500 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Operating Lease Right Of Use Asset Amortization Expense 14000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Payment For Fractional Shares Reverse Stock Split 1000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20240331 Research And Development Expense 933000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Retained Earnings Accumulated Deficit -42786000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Share Based Compensation 220000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20240331 Weighted Average Number Of Diluted Shares Outstanding 18665.0000 shares 1 us-gaap/2024
0001824293-25-000073 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 37000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Assets Current 5615000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20231231 Common Stock Shares Outstanding 2909.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20241231 Common Stock Value Outstanding 0.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 General And Administrative Expense 1411000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Liabilities And Stockholders Equity 4042000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Net Cash Provided By Used In Operating Activities -1736000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Proceeds From Issuance Of Common Stock 5500000.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= Through Financing;
0001824293-25-000073 20250331 Proceeds From Issuance Of Common Stock 3605000.0000 USD 3 us-gaap/2024 Subsidiary Sale Of Stock= At The Market Offering;
0001824293-25-000073 20241231 Property Plant And Equipment Net 4000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Retained Earnings Accumulated Deficit -39740000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Stock Issued During Period Value Fractional Share Adjustment 1000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Stock Issued During Period Value Fractional Share Adjustment 1000.0000 USD 1 0001824293-25-000073 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20250331 Accrued Liabilities Current 1368000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Assets 4042000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Change In Fair Value Of Warrant Liability 0.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001824293-25-000073 20240331 General And Administrative Expense 962000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Increase Decrease In Operating Lease Liability -11000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Net Cash Provided By Used In Financing Activities -11000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Operating Lease Right Of Use Asset 109000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Payments Of Stock Issuance Costs 10000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Recognition Of Right Of Use Assets And Lease Liabilities 152000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Research And Development Expense 1640000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Share Based Compensation 37000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20231231 Stockholders Equity 259000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20231231 Stockholders Equity 31792000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20241231 Stockholders Equity 4032000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Stockholders Equity -42786000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001824293-25-000073 20240331 Stock Issued During Period Shares New Issues 1495.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20250331 Weighted Average Number Of Diluted Shares Outstanding 525447.0000 shares 1 us-gaap/2024
0001824293-25-000073 20240331 Weighted Average Number Of Shares Outstanding Basic 18665.0000 shares 1 us-gaap/2024
0001824293-25-000073 20241231 Common Stock Shares Outstanding 525485.0000 shares 0 us-gaap/2024
0001824293-25-000073 20240331 Fair Value Adjustment Of Warrants -2000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Net Cash Provided By Used In Financing Activities 4486000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20241231 Operating Lease Right Of Use Asset 120000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Payment For Fractional Shares Reverse Stock Split 0.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Prepaid Expense And Other Assets Current 649000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Recognition Of Right Of Use Assets And Lease Liabilities 0.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Stockholders Equity 1205000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Stockholders Equity 43991000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20240331 Stock Issued During Period Shares Fractional Share Adjustment 1.0000 shares 1 0001824293-25-000073 Equity Components= Common Stock;
0001824293-25-000073 20241231 Additional Paid In Capital Common Stock 43772000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Assets Current 3930000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Cash And Cash Equivalents At Carrying Value 3281000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1808000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 2283000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001824293-25-000073 20250331 Common Stock Shares Outstanding 525358.0000 shares 0 us-gaap/2024
0001824293-25-000073 20250331 Common Stock Value Outstanding 0.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid 97000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20240331 Earnings Per Share Diluted -101.0500 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Fair Value Adjustment Of Warrants 0.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Increase Decrease In Accounts Payable -744000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -564000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -196000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Interest Income Expense Nonoperating Net 6000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Liabilities Current 2779000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Net Cash Provided By Used In Operating Activities -2203000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Operating Expenses 3051000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Operating Lease Liability Current 50000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20240331 Payments Of Stock Issuance Costs 1014000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250430 Proceeds From Issuance Of Common Stock 399000.0000 USD 0 us-gaap/2024 Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= At The Market Offering;
0001824293-25-000073 20240331 Stockholders Equity 36218000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20241231 Stockholders Equity 43772000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001824293-25-000073 20241231 Stockholders Equity -39740000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001824293-25-000073 20250331 Stock Issued During Period Shares Fractional Share Adjustment 127.0000 shares 1 0001824293-25-000073 Equity Components= Common Stock;
0001824293-25-000073 20241231 Accrued Liabilities Current 691000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Additional Paid In Capital Common Stock 43991000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001824293-25-000073 20241231 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001824293-25-000073 20240331 Common Stock Shares Outstanding 14450.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20241231 Common Stock Shares Outstanding 525485.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20250331 Common Stock Shares Outstanding 525358.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001824293-25-000073 20250331 Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid 247000.0000 USD 1 0001824293-25-000073
0001824293-25-000073 20250331 Earnings Per Share Basic -5.8000 USD 1 us-gaap/2024
0001824293-25-000073 20240331 Increase Decrease In Accrued Liabilities -172000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Interest Income Expense Nonoperating Net 5000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Net Income Loss -3046000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20250331 Operating Lease Liability Noncurrent 58000.0000 USD 0 us-gaap/2024
0001824293-25-000073 20250331 Operating Lease Right Of Use Asset Amortization Expense 11000.0000 USD 1 us-gaap/2024
0001824293-25-000073 20231231 Stockholders Equity -31533000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Interest Income Expense Nonoperating Net us-gaap/2024 0 0 monetary D C Interest Income (Expense), Nonoperating Amount of interest income (expense) classified as nonoperating.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Stock Issued During Period Shares Warrant Exercise 0001824293-25-000073 1 0 shares D Stock Issued During Period, Shares, Warrant Exercise Stock Issued During Period, Shares, Warrant Exercise
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Shares Fractional Share Adjustment 0001824293-25-000073 1 0 shares D Stock Issued During Period, Shares, Fractional Share Adjustment Stock Issued During Period, Shares, Fractional Share Adjustment
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Change In Fair Value Of Warrant Liability 0001824293-25-000073 1 0 monetary D C Change In Fair Value Of Warrant Liability Change In Fair Value Of Warrant Liability
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid 0001824293-25-000073 1 0 monetary D C Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid
Payments Of Stock Issuance Costs us-gaap/2024 0 0 monetary D C Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Payment For Fractional Shares Reverse Stock Split 0001824293-25-000073 1 0 monetary D C Payment For Fractional Shares, Reverse Stock Split Payment For Fractional Shares, Reverse Stock Split
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Stock Issued During Period Value Fractional Share Adjustment 0001824293-25-000073 1 0 monetary D D Stock Issued During Period, Value, Fractional Share Adjustment Stock Issued During Period, Value, Fractional Share Adjustment
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Common Stock Value Outstanding us-gaap/2024 0 0 monetary I C Common Stock, Value, Outstanding Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Recognition Of Right Of Use Assets And Lease Liabilities 0001824293-25-000073 1 0 monetary D D Recognition Of Right Of Use Assets And Lease Liabilities Recognition Of Right Of Use Assets And Lease Liabilities

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001824293-25-000073 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001824293-25-000073 2 4 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001824293-25-000073 2 5 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001824293-25-000073 2 6 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001824293-25-000073 2 7 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets 0
0001824293-25-000073 2 8 BS 0 H Assets us-gaap/2024 Total assets 0
0001824293-25-000073 2 11 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001824293-25-000073 2 12 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0001824293-25-000073 2 13 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities, current 0
0001824293-25-000073 2 14 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001824293-25-000073 2 15 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, non-current 0
0001824293-25-000073 2 16 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001824293-25-000073 2 17 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 9) 0
0001824293-25-000073 2 19 BS 0 H Common Stock Value Outstanding us-gaap/2024 Common stock, 0.0001 par value; 250,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 525,358 and 525,485 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0
0001824293-25-000073 2 20 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0001824293-25-000073 2 21 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001824293-25-000073 2 22 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001824293-25-000073 2 23 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0001824293-25-000073 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in usd per share) 0
0001824293-25-000073 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001824293-25-000073 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0001824293-25-000073 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding (in shares) 0
0001824293-25-000073 4 2 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001824293-25-000073 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001824293-25-000073 4 4 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001824293-25-000073 4 5 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001824293-25-000073 4 6 IS 0 H Change In Fair Value Of Warrant Liability 0001824293-25-000073 Change in fair value of warrant liability 0
0001824293-25-000073 4 7 IS 0 H Interest Income Expense Nonoperating Net us-gaap/2024 Interest income 0
0001824293-25-000073 4 8 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001824293-25-000073 4 9 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share of common stock, basic (in usd per share) 0
0001824293-25-000073 4 10 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share of common stock, diluted (in usd per share) 0
0001824293-25-000073 4 11 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average common shares outstanding, basic (in shares) 0
0001824293-25-000073 4 12 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average common shares outstanding, diluted (in shares) 0
0001824293-25-000073 5 9 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Beginning balance (in shares) 0
0001824293-25-000073 5 10 EQ 0 H Stockholders Equity us-gaap/2024 Beginning balance 0
0001824293-25-000073 5 11 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0001824293-25-000073 5 12 EQ 0 H Stock Issued During Period Shares Fractional Share Adjustment 0001824293-25-000073 Fractional share adjustment (in shares) 1
0001824293-25-000073 5 13 EQ 0 H Stock Issued During Period Value Fractional Share Adjustment 0001824293-25-000073 Fractional share adjustment 1
0001824293-25-000073 5 14 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock and prefunded warrants in financing (in shares) 0
0001824293-25-000073 5 15 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock and prefunded warrants in financing 0
0001824293-25-000073 5 16 EQ 0 H Stock Issued During Period Shares Warrant Exercise 0001824293-25-000073 Prefunded warrant exercise (in shares) 0
0001824293-25-000073 5 17 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001824293-25-000073 5 18 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Ending balance (in shares) 0
0001824293-25-000073 5 19 EQ 0 H Stockholders Equity us-gaap/2024 Ending balance 0
0001824293-25-000073 6 7 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001824293-25-000073 6 9 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0001824293-25-000073 6 10 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0001824293-25-000073 6 11 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 0
0001824293-25-000073 6 12 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Change in operating lease right-of-use assets 0
0001824293-25-000073 6 14 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001824293-25-000073 6 15 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0001824293-25-000073 6 16 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued expenses 0
0001824293-25-000073 6 17 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease liabilities 0
0001824293-25-000073 6 18 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Cash used in operating activities 0
0001824293-25-000073 6 20 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Proceeds from issuance of common stock in financing transactions 0
0001824293-25-000073 6 21 CF 0 H Payment For Fractional Shares Reverse Stock Split 0001824293-25-000073 Payment for fractional shares in connection with reverse stock split 1
0001824293-25-000073 6 22 CF 0 H Payments Of Stock Issuance Costs us-gaap/2024 Payment of deferred stock issuance costs 1
0001824293-25-000073 6 23 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Cash (used in) provided by financing activities 0
0001824293-25-000073 6 24 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net (decrease) increase in cash and cash equivalents 0
0001824293-25-000073 6 25 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001824293-25-000073 6 26 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001824293-25-000073 6 28 CF 0 H Recognition Of Right Of Use Assets And Lease Liabilities 0001824293-25-000073 Recognition of right-of-use assets and lease liabilities 0
0001824293-25-000073 6 29 CF 0 H Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid 0001824293-25-000073 Deferred stock issuance costs in accounts payable and accrued expenses 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.